These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 29707644)

  • 1. Innovative Bioluminometric Quantification of Cancer Cell Load in Target Organs: Implications for Studying Anticancer Drugs, Including ROS Enhancers.
    Zhu H; Kauffman ME; Li JZ; Sarkar S; Trush MA; Jia Z; Li YR
    React Oxyg Species (Apex); 2016; 1(2):157-164. PubMed ID: 29707644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nrf2 Deficiency Promotes Melanoma Growth and Lung Metastasis.
    Zhu H; Jia Z; Trush MA; Li YR
    React Oxyg Species (Apex); 2016; 2(4):308-314. PubMed ID: 29721548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Simple Bioluminescence Imaging Method for Studying Cancer Cell Growth and Metastasis after Subcutaneous Injection of Lewis Lung Carcinoma Cells in Syngeneic C57BL/6 Mice.
    Zhu H; Kauffman ME; Trush MA; Jia Z; Li YR
    React Oxyg Species (Apex); 2018 Mar; 5(14):118-125. PubMed ID: 29780885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of mouse melanoma cell lines by their mortal malignancy using an experimental metastatic model.
    Nakamura K; Yoshikawa N; Yamaguchi Y; Kagota S; Shinozuka K; Kunitomo M
    Life Sci; 2002 Jan; 70(7):791-8. PubMed ID: 11833741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of [
    Vermeulen K; Naus E; Ahamed M; Attili B; Siemons M; Luyten K; Celen S; Schymkowitz J; Rousseau F; Bormans G
    Theranostics; 2019; 9(2):554-572. PubMed ID: 30809293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cell-based drug delivery system for lung targeting: II. Therapeutic activities on B16-F10 melanoma in mouse lungs.
    Shao J; DeHaven J; Lamm D; Weissman DN; Malanga CJ; Rojanasakul Y; Ma JK
    Drug Deliv; 2001; 8(2):71-6. PubMed ID: 11400865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous administration of bone marrow-derived multipotent mesenchymal stromal cells enhances the recruitment of CD11b(+) myeloid cells to the lungs and facilitates B16-F10 melanoma colonization.
    Souza LE; Almeida DC; Yaochite JN; Covas DT; Fontes AM
    Exp Cell Res; 2016 Jul; 345(2):141-9. PubMed ID: 26027946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancing CTL responses to melanoma cell vaccines in vivo: synergistic increases obtained using IFNgamma primed and IFNbeta treated B7-1+ B16-F10 melanoma cells.
    Dezfouli S; Hatzinisiriou I; Ralph SJ
    Immunol Cell Biol; 2003 Dec; 81(6):459-71. PubMed ID: 14636243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantifying spontaneous metastasis in a syngeneic mouse melanoma model using real time PCR.
    Deng W; McLaughlin SL; Klinke DJ
    Analyst; 2017 Aug; 142(16):2945-2953. PubMed ID: 28725894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of the biological effects of anti-cell adhesive synthetic peptides that inhibit experimental metastasis of B16-F10 murine melanoma cells.
    Humphries MJ; Yamada KM; Olden K
    J Clin Invest; 1988 Mar; 81(3):782-90. PubMed ID: 3343338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of [
    Vermeulen K; Ahamed M; Luyten K; Bormans G
    Nucl Med Biol; 2019; 74-75():1-11. PubMed ID: 31421440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of thymosin beta4 in tumor metastasis and angiogenesis.
    Cha HJ; Jeong MJ; Kleinman HK
    J Natl Cancer Inst; 2003 Nov; 95(22):1674-80. PubMed ID: 14625258
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Cao C; Su Y; Gao Y; Luo C; Yin L; Zhao Y; Chen H; Xu A
    Evid Based Complement Alternat Med; 2018; 2018():4969028. PubMed ID: 30046339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the immunomodulator LS 2616 on growth and metastasis of the murine B16-F10 melanoma.
    Kalland T
    Cancer Res; 1986 Jun; 46(6):3018-22. PubMed ID: 3486041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth inhibition of established B16-F10 lung metastases by sequential aerosol delivery of p53 gene and 9-nitrocamptothecin.
    Gautam A; Waldrep JC; Densmore CL; Koshkina N; Melton S; Roberts L; Gilbert B; Knight V
    Gene Ther; 2002 Mar; 9(5):353-7. PubMed ID: 11938455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Inhibitory effect of tripeptide compound tyroservaltide on invasion and metastasis of mouse melanoma cell line B16-F10].
    Che XC; Lu R; Hu JX; Zheng MN; Zhang MF; Wang S; Yu CY; Yang XL; Xing DH; Yao Z
    Ai Zheng; 2006 Mar; 25(3):275-80. PubMed ID: 16536978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Organ selectivity for implantation survival and growth of B16 melanoma variant tumor lines.
    Fidler IJ; Nicolson GL
    J Natl Cancer Inst; 1976 Nov; 57(5):1199-202. PubMed ID: 1003551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effects of
    Brunetti RL; Da Paz DPA; Da Fonseca IIM; Nagamine MK; Mori CMC; Del Grande MP; Queiroz-Hazarbassanov N; Salles-Gomes COM; Dagli MLZ; Hernandez-Blazquez FJ
    Mol Clin Oncol; 2019 Nov; 11(5):511-516. PubMed ID: 31620282
    [No Abstract]   [Full Text] [Related]  

  • 19. Extraction of immunogenic and suppressogenic antigens from variants of B16 melanoma exhibiting low or high metastatic potentials.
    LeGrue SJ; Hearn DR
    Cancer Res; 1983 Nov; 43(11):5106-11. PubMed ID: 6616449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of melanocortin 1 receptor slows melanoma growth, reduces tumor heterogeneity and increases survival.
    Kansal RG; McCravy MS; Basham JH; Earl JA; McMurray SL; Starner CJ; Whitt MA; Albritton LM
    Oncotarget; 2016 May; 7(18):26331-45. PubMed ID: 27028866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.